August 24, 2017 Endpoints News On a roll, Apellis adds positive PhII C3 data for AMD drug, preps for PhIII August 10, 2017 Endpoints News Apellis grabs $60M to pay for a looming PhIII showdown with Alexion’s Soliris
August 24, 2017 Endpoints News On a roll, Apellis adds positive PhII C3 data for AMD drug, preps for PhIII
August 10, 2017 Endpoints News Apellis grabs $60M to pay for a looming PhIII showdown with Alexion’s Soliris